ID

16797

Descrizione

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00151775

collegamento

https://clinicaltrials.gov/show/NCT00151775

Keywords

  1. 07/08/16 07/08/16 -
Caricato su

7 agosto 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT00151775

Eligibility Hypertension NCT00151775

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient's seated systolic bp (sesbp) will be greater than or equal to 95th percentile for gender and height-for- age, or greater than or equal to 90th percentile if the patient is diabetic, or has glomerular kidney disease, or has a family history of hypertension.
Descrizione

seated systolic blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1319893
negative for hepatitis b and c
Descrizione

negative for hepatitis b and c

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
negative for hiv
Descrizione

negative for hiv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient should not have serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial.
Descrizione

Serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
known sensitivity to olmesartan medoxomil
Descrizione

Sensitivity to olmesartan medoxomil

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0386393
taking prohibited medication
Descrizione

prohibited medication

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0683610
consumed greater than 180 mg of caffeine daily
Descrizione

Caffeine consumption

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0948365
malignant hypertension
Descrizione

Malignant hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0020540
history of congestive heart failure, cardiomyopathy, or obstructive valve disease
Descrizione

congestive heart failure, cardiomyopathy, or obstructive valve disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0878544
UMLS CUI [3,1]
C0018824
UMLS CUI [3,2]
C0549186
renal transplant within the previous 6 months
Descrizione

Renal transplant

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022671
severe nephritic syndrome not in remission
Descrizione

Nephritic syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0268732

Similar models

Eligibility Hypertension NCT00151775

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
seated systolic blood pressure
Item
the patient's seated systolic bp (sesbp) will be greater than or equal to 95th percentile for gender and height-for- age, or greater than or equal to 90th percentile if the patient is diabetic, or has glomerular kidney disease, or has a family history of hypertension.
boolean
C1319893 (UMLS CUI [1])
negative for hepatitis b and c
Item
negative for hepatitis b and c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
negative for hiv
Item
negative for hiv
boolean
C0019693 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial
Item
patient should not have serious other conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patient in the trial.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Sensitivity to olmesartan medoxomil
Item
known sensitivity to olmesartan medoxomil
boolean
C0020517 (UMLS CUI [1,1])
C0386393 (UMLS CUI [1,2])
prohibited medication
Item
taking prohibited medication
boolean
C0013227 (UMLS CUI [1,1])
C0683610 (UMLS CUI [1,2])
Caffeine consumption
Item
consumed greater than 180 mg of caffeine daily
boolean
C0948365 (UMLS CUI [1])
Malignant hypertension
Item
malignant hypertension
boolean
C0020540 (UMLS CUI [1])
congestive heart failure, cardiomyopathy, or obstructive valve disease
Item
history of congestive heart failure, cardiomyopathy, or obstructive valve disease
boolean
C0018802 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0018824 (UMLS CUI [3,1])
C0549186 (UMLS CUI [3,2])
Renal transplant
Item
renal transplant within the previous 6 months
boolean
C0022671 (UMLS CUI [1])
Nephritic syndrome
Item
severe nephritic syndrome not in remission
boolean
C0268732 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial